Tu MM, Abdel-Hafiz HA, Jones RT, et al. "Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy." Commun Biol. 2020;3(1):720.Hany Abdel-Hafiz, PhDDisplay on main departmental publications list: Yes
